A Phase 3, Randomized, Double-Blind, Multicenter, Active-Controlled Trial To Evaluate The Efficacy And Safety Of Celecoxib (CelebrexĀ®) And Indomethacin In The Treatment Of Moderate To Severe Acute Gouty Arthritis
A Phase 3, Randomized, Double-Blind, Multicenter, Active-Controlled Trial To Evaluate The Efficacy And Safety Of Celecoxib (CelebrexĀ®) And Indomethacin In The Treatment Of Moderate To Severe Acute Gouty Arthritis
This is a multicenter, double-blind, double-dummy, randomized, active-controlled study that will include an 8-day treatment period followed by a 1-week follow-up period in patients experiencing symptoms of an acute exacerbation of gouty arthritis.
Inclusion Criteria:
Exclusion Criteria:
Phayathai, Bangkok 10400, Thailand